Conclusions
The present study offers a unique prospective and robust assessment of
the safety of pertussis vaccination during pregnancy and provides
reaffirming evidence of the safety of maternal pertussis vaccination for
both mothers and their infants. Evidence presented in our study provide
further reassurance to expecting women and healthcare providers about
the safety of pertussis vaccination during pregnancy and supports
recommendations for pertussis vaccination during pregnancy to prevent
morbidity and mortality associated with early-infant pertussis disease.
The study findings also aid evidence-based decision making for
clinicians and policy makers in countries considering implementation of
universal maternal pertussis immunisation programs.